Remove 2007 Remove FDA Remove Healthcare
article thumbnail

Competition is on the horizon for costly narcolepsy treatments

pharmaphorum

Sodium oxybate — which in the late 1980s was marketed to bodybuilders and then became known as GHB and criminally used as a date rape drug — has been sold under the brand name Xyrem after gaining FDA approval in 2002. In 2020, the FDA-approved indication was expanded to include those patients who suffer from cataplexy.

article thumbnail

Innovating allergy drug delivery with a needle-free alternative

European Pharmaceutical Review

This decision was granted a couple of weeks following approval by the US and Drug Administration (FDA). 2007; 2(1):5-11. In August 2024, the European Commission approved EURneffy (adrenaline nasal spray) in the EU as the first needle-free emergency option to treat anaphylaxis. 2022 ; 17(11). Fitzcharles-Bowe C et al. Hand (N Y).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma Sales To Med Device CEO: The Jeff Smith Story Part 2

Evolve Your Success

It was 2007 and 2008. We got a couple of our products FDA cleared and we raised our first venture financing. We sold it in a structured deal, meaning you get a little upfront, a little when they’re done, a little with the FDA, and then a piece of the sale for quite some time. That’s the fun part about healthcare innovation.

Sales 130
article thumbnail

15 Top Venture Capital for Biotech Companies

Medico Reach

Technology and healthcare are two areas in which California-based New Enterprise Associates, Inc invests. OrbiMed Healthcare Fund Management. The New York-based OrbiMed Healthcare Fund Management has made various investments in the life sciences, including MedTech and biopharma. New Enterprise Associates. CEO : Luke Goh.

article thumbnail

Interview: Dr Alan S Louie – US Food and Drug Administration Delays

Pharmaceutical Technology

Nicola Boyes: The FDA has come under criticism recently for extreme delays in approving new drugs for the market, is the criticism valid and if so how are the delays impacting on the US pharmaceutical industry at present? In terms of concerns over safety, it has meant that the FDA has been essentially very cautious in moving forward.

article thumbnail

Enterprising Yourself At The Top Of The Spine Distributorship Game With Daniel Tighe

Evolve Your Success

This is 2007. Keep investing even though it’s harder right now with the various taxes that you have and the increased expenses for doing research and FDA approvals. I said, “At some point, I’m going to leave this space and I’m going to go coach on my own,” and then the rest of history. Keep giving me new stuff.

Doctors 246
article thumbnail

Our healthcare has failed us

World of DTC Marketing

IN SUMMARY: American healthcare is failing. Not only has the FDA become a political pawn but almost half the population is now obese. While there are lots of reasons for this the silence of healthcare providers is a huge reason. The post Our healthcare has failed us appeared first on World of DTC Marketing.com.